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Objectives: To comparatively evaluate lobectomy and limited resection for 
T1 NO M0 non-small-cell lung cancer, we reviewed case series with 
concurrent nonrandomized controls. Methods: Limited resection with cur- 
ative intent was performed for 63 patients with T1 NO M0 non-small-cell 
lung cancer over a 10-year period. These 63 patients included 46 patients 
who underwent a segmentectomy as an intentional limited resection. These 
patients had good pulmonary function and could tolerate a lobectomy in the 
management of their disease. The other 17 patients underwent wedge 
resection or segmentectomy as a compromised limited resection because 
they had poor pulmonary reserve or other limiting factors and could 
withstand a thoracotomy but could not tolerate a lobectomy in the 
management of their disease. Results: The 5-year survival was 93% in the 
intentional resection group. The survival curve for this group was not 
different from that for 77 patients who underwent the standard operation 
(lobectomy plus complete mediastinal lymph node dissection) for T1 NO M0 
non-small-cell lung cancer during the same period. The frequency of 
local/regional recurrence in the intentional resection group was 8.7% 
(4/46); the recurrence in three patients was situated in the mediastinum. 
According to multivariate analysis, limited resection was not associated 
with poor survival. Conclusion: Segmentectomy with regional ymph node 
dissection, including the mediastinum, should be considered as an accept- 
able alternative treatment for selected patients with T1 NO M0 disease. 
(J Thorac Cardiovasc Surg 1997;114:347-53) 
R ecently', a prospective randomized trial disclosed an unfavorable result after limited resection for 
the management of patients with T1 NO non-small- 
cell lung cancer (NSCLC) as compared with lobec- 
tomy because of the higher frequency of local/ 
regional recurrence with the limited operation. 1 On 
the other hand, a slightly better survival for the 
segmentectomy group, as compared with the lobec- 
tomy group, was reported in a retrospective nonran- 
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domized study, z Moreover, the treatment of patients 
having bilateral synchronous and metachronous pri- 
mary tumors with standard pulmonary resection for 
one tumor and lesser resection for the contralateral 
tumor has certainly provided a curative procedure 
for many individuals) 
The following report describes our retrospective 
review of patients with T1 NO M0 NSCLC treated at 
Osaka Medical Center for Cancer & Cardiovascular 
Diseases. In the past decade the surgeons at this 
hospital have performed segmentectomy for se- 
lected patients whose lung function is adequate to 
tolerate a standard lobectomy. 
Patients and methods 
Patient population. Between January 1985 and Sep- 
tember 1996, 913 patients with NSCLC (squamous cell 
carcinoma, denocarcinoma, or large-cell carcinoma) un- 
derwent resections at Osaka Medical Center for Cancer & 
Cardiovascular Diseases. Among 181 of these patients 
who were pathologically classified as having T1 NO M0 
carcinoma located in the peripheral lung parenchyma, 63 
patients (34.8%) underwent limited resection and 77 
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patients (42.5%) had a standard lobectomy procedure 
(lobectomy plus complete mediastinal lymph node dissec- 
tion). Forty-six of the 63 patients (25.4%) who underwent 
a limited operation had been considered suitable candi- 
dates for a standard lobectomy procedure with mediasti- 
nal lymph node dissection. This determination was made 
after assessing pulmonary function with spirometry and 
examination of arterial blood gases. These patients were 
classified as the intentional resection group. We started 
doing this procedure in 1985. The additional 17 patients 
(9.4%) who underwent limited operations were consid- 
ered unsuitable candidates for lobectomy because of poor 
pulmonary reserve, combined iseases uch as coronary 
artery disease, or older age, and were classified as the 
compromised resection group. Forty-one patients (22.7%) 
who underwent lobectomy without mediastinal lymph 
node dissection were excluded from the present study. 
After obtaining informed consent from the patients 
regarding the operative methods, we decided what type of 
resection to perform after eviewing the preoperative and 
intraoperative findings (tumor shape, location, size, and 
lymph node status). In deciding whether to apply an 
intentional limited resection, we also carefully considered 
the predicted residual lobar volume. As a rule, we per- 
formed a limited resection in patients with a tumor less 
than 2 cm in diameter with a well-defined margin in the 
peripheral lung parenchyma. Even though smaller than 2 
cm in diameter, tumors showing strong spicula in the 
preoperative computed tomographic scans were consid- 
ered contraindications for limited resection. 
Surgical procedures. Segmentectomy or bisubsegmen- 
tectomy was applied in all patients in the intentional 
resection group and in 14 of the 17 patients in the 
compromised resection group. Three patients in the latter 
group underwent wedge resection. General anesthesia 
with the use of a double-lumen endotracheal tube was 
standard at this time. A lateral muscle-sparing thoracot- 
omy and laser segmentectomy performed with a neody- 
mium:yttrium-aluminum-garnet (Nd:YAG) laser was 
used in most cases.  We 4 have previously described the 
precise details of how this laser is used. In brief, before a 
decision regarding the amount of lung tissue to be re- 
moved was made, bronchial node biopsies were per- 
formed and the specimens submitted for frozen section 
examination. After hilar management, nonanatomic re- 
section of the lung parenchyma was carried out with a 
noncontact laser-focusing handpiece to maintain a con- 
stant safety margin of about 3 cm from the tumor edge. 
When the tumor extended across the intersegmental lung 
parenchyma, two subsegmental bronchi were resected to 
maintain the constant safety margin. The small vessels and 
bronchioles in the laser-irradiated field were carefully 
ligated. 
Statistical analysis. The survival curves and the pat- 
terns of recurrences ofthese three groups were compared. 
The survival curves were calculated by the Kaplan-Meier 
method, and the statistical comparisons among the curves 
were made by means of the log-rank test. We defined 
local/regional recurrence as the development of an addi- 
tional carcinoma in the mediastinum or the resected 
margin. Unpaired two-tailed t tests were used for the 
comparison of mean values. The X 2 test was used to 
compare observed percentages. Variables related to sur- 
vival in patients with standard lobectomy or intentional 
limited resection were analyzed by Cox's proportional 
hazards regression model with SAS software (SAS Insti- 
tute, Inc., Cary, N.C.). Values of p less than 0.05 were 
considered to be statistically significant. 
Results 
One hundred forty patients aged 35 to 87 years 
were studied. As shown in Table I, 77 standard 
operations were performed, 46 intentional limited 
operations and 17 compromised limited operations. 
The average age in the compromised resection 
group was significantly higher than that in either of 
the other two groups (p < 0.0001). The median 
follow-up period was 83 months for the standard 
lobectomy group, 30 months for the intentional 
resection group, and 61 months for the compro- 
mised resection group. The high percentage of men 
was characteristic of patients having compromised 
limited resection. The difference in the distribution 
of histologic types among these three groups was not 
statistically significant. The average diameter for 
pulmonary nodules was 22.9 mm in the standard 
resection group, 16.7 mm in the intentional resec- 
tion group, and 22.4 mm in the compromised resec- 
tion group. Overall, tumors in the intentional resection 
group were smaller than those in the other two groups 
(p < 0.0001 and p < 0.001). The forced expiratory 
volume in 1 second of the compromised resection 
group was significantly worse than that of the other 
two groups (p = 0.006 andp < 0.001). Arterial oxygen 
tension did not differ significantly among these three 
groups. 
The tumors were primarily located in the upper 
lobes (41 [65%]: right, n --- 21; left, n = 20). 
Twenty-two tumors (35%) were located in the lower 
lobes (right, n = 9; left, n = 13). 
All but three of the patients in the compromised 
resection group underwent segmentectomy or 
bisubsegmentectomy. In the intentional resection 
group, 13 patients underwent hilar and complete 
mediastinal lymph node dissection, and 28 under- 
went hilar node dissection with incomplete medias- 
tinal lymph node dissection. An additional five 
patients did not undergo lymph node dissection 
because of no detectable lymph node on computed 
tomography. On the other hand, mediastinal lymph 
node dissection was not attempted in any of the 17 
patients in the compromised resection group. 
We initially attempted an intentional limited op- 
eration in an additional six patients. However, fro- 
zen section and intraoperative histologic diagnostic 
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Table I. Background 
Limited operation 
Standard lobectomy* Intentional Compromised 
No. of patients 
Age (yr) (range) 
Sex (Mj~) 
Median follow-up (mo) 
Histologic type 
Squamous cell 
Adenocarcinoma 
Large cell 
Tumor diameter (ram) (mean _+ SD) 
Preop. respiratory function (mean ± SD) 
FEV~(L) 
FVC (L) 
77 
61 (39-87) 
l 
46/31 
I 
83 
- -  p 0.03 
46 17 
61(35-77) 73(58-8~) 
L - -  p<0.0001 
31/15 15/2 
l 
30 61 
13 
61 
3 
22.9 ± 5.22 
t __  p < 0.0001 _ _  
8 7 
36 10 
2 0 
16.7 _+ 4.97 22.4 _+ 6.61 
J I p<0.001 __ J  
2.33 ± 0.69 
l _ _  
2.91 _+ 0.79 
I 
p = 0.006 
p = 0.08 
2.46 _+ 0.57 1.77 -+ 0.57 
I p < 0.001 I / 
l 
3.09 -+ 0.66 2.49 -+ 0.64 
I p = 0.005 I / 
J 
SD, Standard eviation; Preop., preoperative; FEVz, forced expiratory volume in 1 second; FVC, forced vital capacity. 
*Lobectomy with mediastinal lymph node dissection. 
evaluation confirmed N2 disease in two of these 
patients, and they were thus excluded from the 
present study because their disease had progressed 
to a different stage. Four of these patients had an 
insufficient safe margin and were thus included in 
the standard lobectomy group because we altered 
the procedure from segmentectomy to lobectomy 
with mediastinal lymph node dissection. 
The overall survival proportion at 5 years calcu- 
lated by the Kaplan-Meier method (Fig. 1) was 88% 
in the standard lobectomy group and 93% in the 
intentional resection group. No statistically signifi- 
cant difference between these two groups was de- 
tected in the survival curves (p = 0.86). However, in 
the compromised resection group, the 5-year sur- 
vival was 48%. The survival curve in the compro- 
mised resection group was significantly lower than 
those in the other two groups (p < 0.001 and p = 
0.003). 
The clinical outcome in each group is presented in
Table II. No operation-related deaths occurred. In 
the standard lobectomy group, three patients (3.9%) 
died of lung cancer ecurrence. In this group, deaths 
from other causes included death from other can- 
cers, deaths causes unrelated to cancer, and death 
from unknown causes. Sixty-six patients (85.7%) are 
alive with no evidence of disease, and two (2.6%) 
are alive with recurrent disease. In the intentional 
resection group, four patients (8.7%) died of lung 
cancer ecurrence. Forty patients (87.0%) are alive 
with no evidence of disease, and two (4.3%) are 
alive with recurrent disease. In the compromised 
resection group, three patients (17.6%) died of lung 
cancer recurrence. Ten patients (58.8%) are alive 
with no evidence of disease, and one (5.9%) is alive 
with recurrent disease. The incidence of lung cancer 
deaths or recurrences in the compromised resection 
group was higher (p = 0.05) than that in the 
standard lobectomy group. Although noncancer or 
other cancer death was more prevalent in the com- 
promised resection group than in the other two 
groups, the difference was not significant. The 
causes of death in the two patients with noncancer 
death were acute myocardial infarction in one and 
chronic obstructive pulmonary disease in the other. 
The recurrence rates did not differ significantly (p = 
0.49) between the standard lobectomy group and 
the intentional resection group. 
The patterns of tumor recurrence are presented 
in Table III. The frequency of development of 
local/regional recurrence with or without distant 
metastasis n the intentional resection group was not 
higher (p = 0.12) than that in the standard lobec- 
tomy group. The compromised resection group 
showed significantly higher frequency (p = 0.02) of 
local/regional recurrence compared with the lobec- 
tomy group. 
Table IV shows the clinical details for the six 
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Intentional resection 
r~ 40- 
10- 
Compromised resection 
o 1# 
T ime in  Days  
Patients at risk 
Standard 77 66 55 47 38 32 19 10 
Intentional 46 38 22 19 9 6 4 3 
Compromised 17 12 7 3 2 1 
Fig. 1. Comparison of survival curves among the three groups (standard vs intentional:p =0.86; standard 
vs compromised: p < 0.001; intentional vs compromised: p = 0.003). 
Table II. Clinical outcome 
Limited resection 
Standard lobectomy Intentional Compromised 
No. % No. % No. % 
Lung cancer deaths 3 3.9* 4 8.7 3 17.6" 
Other cancer deaths 1 1.3 0 0 1 5.9 
Noncancer death 3 3.9 0 0 2 11.8 
Unknown 2 2.6 0 0 0 0 
Alive 
With recurrence 2 2.6* 2 4.3 1 5.9* 
Without recurrence 66 85.7 40 87.0 10 58.8 
Total 77 100 46 100 17 100 
*The incidence of lung cancer death or recurrence in the compromised resection group is statistically higher (p = 0.05) than that in the standard lobectomy 
group. 
patients with recurrent disease in the intentional 
resection group. Four patients had adenocarcinoma 
and one each had squamous cell carcinoma and 
large-cell carcinoma. Mediastinal ymph node me- 
tastasis or distant metastasis developed in two pa- 
tients with tumor less than 20 mm in diameter. 
Mediastinal recurrence occurred in three patients 
without complete mediastinal lymph node dissection 
(patients 1, 4, and 5). The patient with intrapulmo- 
nary recurrence at the margin and the patient with 
lung metastases in a different lobe both underwent 
successful additional complete resection. They are 
alive with no evidence of disease. In patient 2, 
distant metastases were confined to the extratho- 
racic lymph nodes. 
In three patients in the compromised resection 
group who had local/regional recurrence, the recur- 
rence was in the mediastinum. Of those three pa- 
tients, one also had an intrapulmonary ecurrence at 
the margin after resection of a 25 mm squamous cell 
carcinoma. 
By Cox's multivariate analysis, tumor size and age 
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Table III. Sites of recurrence 
Limited resection 
Standard lobectomy Intentional Compromised 
No. % No. % No. % 
Local/regional 1 1.3" 1 2.2 2 11.8" 
Distant 4 5.2 2 4.3 1 5.9 
Both 0 0* 3 6.5 1 5.9* 
Total 5/77 6.5 6/46 13.0 4/17 23.6 
*The frequency of development of local/regional recurrence with or without distant metastasis in the compromised resection group was statistically higher 
(p = 0.02) than that in the standard lobectomy group. 
Table IV. Clinical details of six patients with recurrent diseases after intentional limited resection for 
T1 NO MO NSCLC 
Patient Size 
No. Age/sex His (mm) Location LyD Laser Recurrence site Results 
1 51/M Sq 17 R-S2 1 - Mdst and lung 119 mo, dead 
2 69/F Ad 18 L-S8 2 - Distant LN 66 too, dead 
3 57/M Ad 25 R-$2-3 2 - Margin* 83 too, alive 
4 75/M La 25 L-$3-4 0 + Mdst and liver 18 too, dead 
5 77/M Ad 24 R-S6 1 + Mdst and liver 32 too, dead 
6 58/F Ad 20 R-$2-3 2 + Lungt 50 too, alive 
His, Histologic type; Sq, squamous cell carcinoma; Ad, 
lung; LyD, lymph node dissection (0 = no lymph node 
mediastinum; LN, lymph node. 
*Completion bilobectomy. 
?Right lower lobectomy. 
adenocarcinoma; L , large-cell carcinoma; R-S, segments ofthe right lung; L-S, segments ofthe left 
dissection; 1 = hilar lymph node dissection; 2 = hilar and mediastinal lymph node dissection); Mdst, 
were independent predictors of survival when con- 
sidered together with sex, surgical procedures (in- 
tentional limited resection vs standard lobectomy), 
and histologic types (Table V). 
Discussion 
Lobectomy combined with regional ymph node 
dissection has long been accepted as the standard 
treatment for lung cancer. Since Jensik and associ- 
ates 5 reported the outcome after segmental resec- 
tion for lung cancer, the procedure has become an 
accepted surgical option for patients with compro- 
mised pulmonary reserve. 6 Segmentectomies have 
also been proposed as the procedure of choice for 
stage I carcinoma of the lung whenever the tumor 
location allows for the procedure. 2 
Recent retrospective analyses by Warren and 
Faber 7suggested that lobectomy offered no survival 
advantage over segmentectomy for patients with 
tumors 3.0 cm in diameter or smaller, but that a 
survival advantage was apparent for patients with 
tumors larger than 3.0 cm. Warren and Faber 7
pointed out that patients undergoing segmental 
pulmonary resections have a 4.6-fold increased risk 
of local/regional recurrence within the next 5 years 
compared with those undergoing lobectomy for 
stage I carcinomas. However, because the majority 
of patients with local/regional recurrence died of 
distant metastases, this did not affect the 5-year 
survival in the two groups. In the study by Read, 
Yoder, and Schaeffer, 2 the proportion surviving was 
slightly better for the segmentectomy group than for 
the lobectomy group with T1 NO M0 disease. Both 
authors 2,7 recommend that, in the absence of dis- 
tant metastases, patients with a local/regional recur- 
rence be treated with additional resection whenever 
possible, rather than with palliative radiotherapy. In 
our study, as a result of the careful selection of 
patients to undergo intentional limited resection, 
the average maximal tumor diameter in the inten- 
tional resection group was significantly smaller than 
those in the standard lobectomy and compromised 
resection groups. Each of the patients with local/ 
regional recurrence and metastases of a different 
ipsilateral lobe was successfully treated with addi- 
tional resection and is presently in good condition. 
A prospective randomized trial of lesser resec- 
tions compared with lobectomy for T1 NO NSCLC 
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Table V. Cox's regression analysis of survival in 123 patients with standard Iobectomy or intentional limited 
resection 
No. of Hazard 
Variables No. deaths ratio 95% CI p Value 
Tumor size (mm) 
<20 55 2 6.0 3.9-9.3 0.04 
->20 68 10 
Age (yr) 
<60 49 1 9.3 5.4-15.9 0.04 
->60 74 11 
Sex 
Male 77 9 0.4 0.3-0.5 0.17 
Female 46 3 
Procedure 
Segmentectomy 46 4 0.4 0.3-0.6 0.19 
Lobectomy 77 8 
Histologic type 
Squamous 21 2 1.3 0.9-2.0 0.71 
Nonsquamous 102 10 
CI, Confidence interval. Nonsquamous includes adenocarcinoma and large-cell carcinoma. 
was conducted by the North American Lung Cancer 
Study Group and reported by Ginsberg and Rubin- 
stein.1 They noted a higher local/regional recurrence 
rate and death rate in the segmentectomy group as 
compared with the lobectomy group. According to 
their report, the importance of accurate intraoper- 
ative staging including lymph node sampling is dem- 
onstrated by the evidence that more than 25% of 
patients with lung cancer deemed to be clinically T1 
N0 were found to have a higher stage of disease 
after the intraoperative primary tumor and lymph 
node assessment. 
Although this is not a randomized study, both 
limited resection and lobectomy have been carried 
out by the same surgical staffs in our institution. In 
our patients the hilar and mediastinal nodes were 
dissected, and the specimens were then submitted 
for frozen section analysis before a decision was 
made regarding the amount of lung to be removed. 
As a result, we could exclude two patients (3%) in 
whom lymph node metastasis was detected. The two 
patients underwent completion lobectomy with me- 
diastinal lymph node dissection. On the other hand, 
six patients had recurrence in the mediastinum after 
intentional or compromised limited resection. This 
may have resulted from insufficient mediastinal 
lymph node dissection. The disease in these eight 
patients (12%) was considered to be at a stage higher 
than stage I. These findings suggest hat complete 
mediastinal lymph node dissection is important not 
only for greater cure rate but also to allow more 
accurate pathologic staging. This procedure had been 
routine at our institution since 1995. When lymph 
node metastasis i  confirmed on intraoperative frozen 
section, the procedure should be altered from a lim- 
ited resection to the standard lobectomy to achieve 
more complete hilar lymphadenectomy. 
Another important goal is to prevent cancer e- 
currence at the resected margin. To achieve this 
objective, we 4 developed the new technique desig- 
nated "radical laser segmentectomy" combined with 
nonanatomic segmentectomy using the Nd:YAG 
laser and lymph node dissection at the pulmonary 
hilum and mediastinum. With this technique, we 
believe that small peripheral tumors located in any 
segments of the upper lobe, or superior or anterior 
basal segments of the lower lobe, become good 
candidates for limited resection. On the other hand, 
for middle lobe and medial, lateral, and posterior 
basal segments of the lower lobe, because of the 
necessity for maintaining a safe margin at least 3 cm 
wide, insufficient residual volume and function in 
the affected lobe may be present after the proce- 
dure. Thus the candidates for limited resection 
should be selected only after careful consideration 
of tumor size, location, and shape. 
In the present study, multivariate analysis dem- 
onstrated that tumor size provides prognostic 
information. Recently, as a result of the develop- 
ment of high-resolution computed tomographic 
scanning, small lung cancers less than 1 cm in 
diameter are being detected more frequently. 
Patients with these tumors are good candidates 
for a limited resection. 
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Although a long-term detailed follow-up is neces- 
sary, the data from our series suggest that, in 
selected patients, a segmentectomy or bisubsegmen- 
tectomy combined with regional lymph node dissec- 
tion including the mediastinum is an acceptable 
option for the management of T1 NO NSCLC. 
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